Wang, D.; Luo, Y.; Wang, X.; Orlicky, D.J.; Myakala, K.; Yang, P.; Levi, M.
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice. Int. J. Mol. Sci. 2018, 19, 137.
https://doi.org/10.3390/ijms19010137
AMA Style
Wang D, Luo Y, Wang X, Orlicky DJ, Myakala K, Yang P, Levi M.
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice. International Journal of Molecular Sciences. 2018; 19(1):137.
https://doi.org/10.3390/ijms19010137
Chicago/Turabian Style
Wang, Dong, Yuhuan Luo, Xiaoxin Wang, David J. Orlicky, Komuraiah Myakala, Pengyuan Yang, and Moshe Levi.
2018. "The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice" International Journal of Molecular Sciences 19, no. 1: 137.
https://doi.org/10.3390/ijms19010137
APA Style
Wang, D., Luo, Y., Wang, X., Orlicky, D. J., Myakala, K., Yang, P., & Levi, M.
(2018). The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice. International Journal of Molecular Sciences, 19(1), 137.
https://doi.org/10.3390/ijms19010137